Infectious diseases Archives - Page 9 of 34

Clinical Articles

Common diabetes drug metformin could protect against long COVID

here are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone

Videos

Protein based COVID-19 vaccine

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access (8 mins).

Podcasts

COVID update – Boosters, side effects, new waves

Vaccine-related injury, long COVID, more on boosters.

Videos

Influenza vaccines for older adults in the 2023 influenza season

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins).This product explainer is supported by Seqirus

Podcasts

COVID Update – It’s not over yet

The current COVID situation- protect your vulnerable patients.

Clinical Articles

When it comes to vaccinations – don’t forget the old

Don’t forget routine immunisations and use any patient contact as an opportunity for vaccination—says Professor Nick Wood of the National Centre for Immunisation Research & Surveillance at the University of Sydney.

Clinical Articles

Cytomegalovirus lies dormant in most US adults and is the leading infectious cause of birth defects, but few have heard of it

“Why didn’t anyone tell me about this virus?” is a frequent response I hear from parents upon learning their newborn is infected with cytomegalovirus, or CMV. Although more than half of the U.S. population will be infected with CMV by the age of 40 and the disease is common worldwide, few people have ever heard of it.

Expert/s: Healthed

Podcasts

COVID update – The 5th wave

WHO vs ATAGI booster advice, which do we use? Antivirals - positive evidence for Molnupiravir emerges.

Videos

Invasive meningococcal disease and the MenACWY-TT conjugate vaccine

In this Product Explainer, Paediatrician Dr Daryl Cheng explains the role of the MenACWY-TT conjugate vaccine for invasive meningococcal disease, the importance of adolescent vaccination and opportunistic immunisation, and the healthcare professional’s role in improving uptake rates in this age group (7 mins).
PP-NIM-AUS-0340. May 2023

Videos

Bivalent original/omicron pre-filled syringe for COVID-19 vaccination

In this Product Explainer, Public Health Physician Prof Paul Van Buynder explains the role of the Bivalent Original/Omicron BA.4-5 pre-filled syringe COVID-19 vaccine and provides an update on the situation in aged care, and how boosters can assist in protecting the community against symptomatic infection and severe disease (5 mins).

Clinical Articles

COVID disaster looming in aged care

Only a fraction of aged care residents are getting COVID boosters, despite high influenza vaccination rates - why the mismatch?

Podcasts

COVID update – Vaccine and variant update

The WHO says the emergency is over - should we believe them? 2nd generation vaccines are needed- vaccine related injury.

Infectious diseases

Common diabetes drug metformin could protect against long COVID

here are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone

Protein based COVID-19 vaccine

COVID update – Boosters, side effects, new waves

Vaccine-related injury, long COVID, more on boosters.

Influenza vaccines for older adults in the 2023 influenza season

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins).This product explainer is supported by Seqirus

COVID Update – It’s not over yet

The current COVID situation- protect your vulnerable patients.

When it comes to vaccinations – don’t forget the old

Don’t forget routine immunisations and use any patient contact as an opportunity for vaccination—says Professor Nick Wood of the National Centre for Immunisation Research & Surveillance at the University of Sydney.

Cytomegalovirus lies dormant in most US adults and is the leading infectious cause of birth defects, but few have heard of it

COVID update – The 5th wave

WHO vs ATAGI booster advice, which do we use? Antivirals - positive evidence for Molnupiravir emerges.

Invasive meningococcal disease and the MenACWY-TT conjugate vaccine

Bivalent original/omicron pre-filled syringe for COVID-19 vaccination

COVID disaster looming in aged care

Only a fraction of aged care residents are getting COVID boosters, despite high influenza vaccination rates - why the mismatch?

COVID update – Vaccine and variant update

The WHO says the emergency is over - should we believe them? 2nd generation vaccines are needed- vaccine related injury.

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Infectious diseases

here are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone

Vaccine-related injury, long COVID, more on boosters.

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins).This product explainer is supported by Seqirus

The current COVID situation- protect your vulnerable patients.

Don’t forget routine immunisations and use any patient contact as an opportunity for vaccination—says Professor Nick Wood of the National Centre for Immunisation Research & Surveillance at the University of Sydney.

WHO vs ATAGI booster advice, which do we use? Antivirals - positive evidence for Molnupiravir emerges.

Only a fraction of aged care residents are getting COVID boosters, despite high influenza vaccination rates - why the mismatch?

The WHO says the emergency is over - should we believe them? 2nd generation vaccines are needed- vaccine related injury.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.